Hello, and apologies for not posting for such a long time.
As one of the few (and greatly privileged) LVV-GCA sufferers in the UK lucky enough to have been prescribed subcutaneous Tocilizumab injections, I have a couple of items of news.
First of all, along with my husband, I have been a participant in the UK BioBank long-term health research project since 2008, (long before I was in anything but tip-top health).
Last week we were offered the chance to take part in the Covid-19 antibody study, looking to see how many people have developed antibodies to Covid, either as a result of infection or from having been vaccinated. I’m delighted to report that we both have antibodies (having received our second dose of Pfizer vaccine 3 weeks ago), and I am still on weekly injections of Tocilizumab.
My second bit of information is that the NHS has apparently extended the prescriptions of Tocilizumab to June - they had been due to end in April.
My consultant told me early in March that my (and everyone else’s extended) prescriptions were due to end in April, and because I am asymptomatic and cannot tolerate the doses of Prednisolone that would be needed in the event of a relapse, on March 8th she had submitted an extensive plea in order to try to get me Individual Patient Funding (IPF) to allow me to stay on Tocilizumab. (It seems that she will now have to start the lengthy IPF application all over again after this latest NHS extension has run out).